RT Journal Article
SR Electronic
T1 Connectome reorganization associated with temporal lobe pathology and its surgical resection
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.11.13.23298482
DO 10.1101/2023.11.13.23298482
A1 Larivière, Sara
A1 Park, Bo-yong
A1 Royer, Jessica
A1 DeKraker, Jordan
A1 Ngo, Alexander
A1 Sahlas, Ella
A1 Chen, Judy
A1 Rodríguez-Cruces, Raúl
A1 Weng, Yifei
A1 Frauscher, Birgit
A1 Liu, Ruoting
A1 Wang, Zhengge
A1 Shafiei, Golia
A1 Mišić, Bratislav
A1 Bernasconi, Andrea
A1 Bernasconi, Neda
A1 Fox, Michael D.
A1 Zhang, Zhiqiang
A1 Bernhardt, Boris C.
YR 2023
UL http://medrxiv.org/content/early/2023/11/13/2023.11.13.23298482.abstract
AB Network neuroscience offers a unique framework to understand the organizational principles of the human brain. Despite recent progress, our understanding of how the brain is modulated by focal lesions remains incomplete. Resection of the temporal lobe is the most effective treatment to control seizures in pharmaco-resistant temporal lobe epilepsy (TLE), making this syndrome a powerful model to study lesional effects on network organization in young and middle-aged adults. Here, we assessed the downstream consequences of a focal lesion and its surgical resection on the brain’s structural connectome, and explored how this reorganization relates to clinical variables at the individual patient level. We included adults with pharmaco-resistant TLE (n = 37) who underwent anterior temporal lobectomy between two imaging time points, as well as age-and sex-matched healthy controls who underwent comparable imaging (n = 31). Core to our analysis was the projection of high-dimensional structural connectome data—derived from diffusion MRI tractography from each subject—into lower-dimensional gradients. We then compared connectome gradients in patients relative to controls before surgery, tracked surgically-induced connectome reconfiguration from pre-to postoperative time points, and examined associations to patient-specific clinical and imaging phenotypes. Before surgery, TLE presented with marked connectome changes in bilateral temporo-parietal regions, reflecting an increased segregation of the ipsilateral anterior temporal lobe from the rest of the brain. Surgery-induced connectome reorganization was localized to this temporo-parietal subnetwork, but primarily involved postoperative integration of contralateral regions with the rest of the brain. Using a partial least-squares analysis, we uncovered a latent clinical-imaging signature underlying this pre-to postoperative connectome reorganization, showing that patients who displayed postoperative integration in bilateral fronto-occipital cortices also had greater preoperative ipsilateral hippocampal atrophy, lower seizure frequency, and secondarily generalized seizures. Our results bridge the effects of focal brain lesions and their surgical resections with large-scale network reorganization and inter-individual clinical variability, thus offering new avenues to examine the fundamental malleability of the human brain.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by CIHRAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Jinling Hospital, Nanjing University School of Medicine gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors